APA (7th ed.) Citation

Gandhi, R., Yang, E., Sangha, P., Ngo, A., Pruett, J., & Fallick, M. (2023). RWD161 Real World Utilization of Androgen Deprivation Therapy Among Urology Practices: Characterizing Initiation and Transition to Relugolix for Patients with Prostate Cancer (THE REAL ADT TRANSITIONS STUDY). Value in Health, 26(6), S392. https://doi.org/10.1016/j.jval.2023.03.2189

Chicago Style (17th ed.) Citation

Gandhi, R., E. Yang, P. Sangha, A. Ngo, J. Pruett, and M. Fallick. "RWD161 Real World Utilization of Androgen Deprivation Therapy Among Urology Practices: Characterizing Initiation and Transition to Relugolix for Patients with Prostate Cancer (THE REAL ADT TRANSITIONS STUDY)." Value in Health 26, no. 6 (2023): S392. https://doi.org/10.1016/j.jval.2023.03.2189.

MLA (9th ed.) Citation

Gandhi, R., et al. "RWD161 Real World Utilization of Androgen Deprivation Therapy Among Urology Practices: Characterizing Initiation and Transition to Relugolix for Patients with Prostate Cancer (THE REAL ADT TRANSITIONS STUDY)." Value in Health, vol. 26, no. 6, 2023, p. S392, https://doi.org/10.1016/j.jval.2023.03.2189.